M A Ghetie - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Blood|November 1, 1992

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxinM A Ghetie, K Tucker, J Richardson, et al.

Blood|August 1, 1994

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktailM A Ghetie, K Tucker, J Richardson, et al.

Journal of Immunological Methods|January 24, 1990

Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chainV Ghetie, M A Till, M A Ghetie, et al.

Journal of Immunological Methods|September 13, 1991

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bondV Ghetie, P Thorpe, M A Ghetie, et al.

Cancer Research|November 1, 1991

Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sitesM A Ghetie, J Richardson, T Tucker, et al.

International Journal of Cancer|March 15, 1990

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID miceM A Ghetie, J Richardson, T Tucker, et al.

Experimental Cell Research|June 1, 1993

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndromeA M Soler-Rodríguez, M A Ghetie, N Oppenheimer-Marks, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 8, 1997

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cellsM A Ghetie, E M Podar, A Ilgen, et al.

International Journal of Cancer|September 27, 1996

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphomaM A Ghetie, E M Podar, B E Gordon, et al.

Blood|March 1, 1994

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrestM A Ghetie, L J Picker, J A Richardson, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Blood|November 1, 1992

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxinM A Ghetie, K Tucker, J Richardson, et al.

Blood|August 1, 1994

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktailM A Ghetie, K Tucker, J Richardson, et al.

Journal of Immunological Methods|January 24, 1990

Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chainV Ghetie, M A Till, M A Ghetie, et al.

Journal of Immunological Methods|September 13, 1991

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bondV Ghetie, P Thorpe, M A Ghetie, et al.

Cancer Research|November 1, 1991

Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sitesM A Ghetie, J Richardson, T Tucker, et al.

International Journal of Cancer|March 15, 1990

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID miceM A Ghetie, J Richardson, T Tucker, et al.

Experimental Cell Research|June 1, 1993

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndromeA M Soler-Rodríguez, M A Ghetie, N Oppenheimer-Marks, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 8, 1997

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cellsM A Ghetie, E M Podar, A Ilgen, et al.

International Journal of Cancer|September 27, 1996

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphomaM A Ghetie, E M Podar, B E Gordon, et al.

Blood|March 1, 1994

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrestM A Ghetie, L J Picker, J A Richardson, et al.

Pageof 3